|
1.6619 %
| NYSE | US5324571083 | LLY-US | Eli Lilly and Company |
1
|
|
1.6463 %
| NYSE | US98978V1035 | ZTS-US | Zoetis, Inc. Class A |
2
|
|
1.6293 %
| NASDAQ | US2210061097 | CRVL-US | CorVel Corporation |
3
|
|
1.5949 %
| NYSE | US1101221083 | BMY-US | Bristol-Myers Squibb Company |
4
|
|
1.5910 %
| NASDAQ | US45168D1046 | IDXX-US | IDEXX Laboratories, Inc. |
5
|
|
1.5629 %
| NYSE | US6075251024 | MODN-US | Model N, Inc. |
6
|
|
1.5551 %
| NASDAQ | US50187A1079 | LHCG-US | LHC Group, Inc. |
7
|
|
1.5508 %
| NASDAQ | US90041T1088 | TPTX-US | Turning Point Therapeutics, Inc. |
8
|
|
1.5481 %
| NYSE | US0017441017 | AMN-US | AMN Healthcare Services, Inc. |
9
|
|
1.5452 %
| NYSE | US16359R1032 | CHE-US | Chemed Corporation |
10
|
|
1.5397 %
| NYSE | US64157F1030 | NVRO-US | Nevro Corp. |
11
|
|
1.5383 %
| NASDAQ | US14843C1053 | CSTL-US | Castle Biosciences, Inc. |
12
|
|
1.5252 %
| NYSE | US7611521078 | RMD-US | ResMed Inc. |
13
|
|
1.5221 %
| NYSE | US8793691069 | TFX-US | Teleflex Incorporated |
14
|
|
1.5177 %
| NASDAQ | US6373722023 | NRC-US | National Research Corporation |
15
|
|
1.5156 %
| NYSE | US74112D1019 | PBH-US | Prestige Consumer Healthcare Inc |
16
|
|
1.5149 %
| NASDAQ | US0234361089 | AMED-US | Amedisys, Inc. |
17
|
|
1.5143 %
| NASDAQ | US5747951003 | MASI-US | Masimo Corporation |
18
|
|
1.5080 %
| NYSE | US81619Q1058 | SEM-US | Select Medical Holdings Corporation |
19
|
|
1.5070 %
| NYSE | IE00BTN1Y115 | MDT-US | Medtronic plc |
20
|
|
1.5023 %
| NASDAQ | US8292141053 | SLP-US | Simulations Plus, Inc. |
21
|
|
1.4992 %
| NYSE | US91324P1021 | UNH-US | UnitedHealth Group Incorporated |
22
|
|
1.4979 %
| NASDAQ | US1167941087 | BRKR-US | Bruker Corporation |
23
|
|
1.4960 %
| NYSE | US1255231003 | CI-US | Cigna Corporation |
24
|
|
1.4925 %
| NASDAQ | US6323071042 | NTRA-US | Natera, Inc. |
25
|
|
1.4902 %
| NASDAQ | US1567821046 | CERN-US | Cerner Corporation |
26
|
|
1.4842 %
| NYSE | US9553061055 | WST-US | West Pharmaceutical Services, Inc. |
27
|
|
1.4840 %
| NASDAQ | US6390501038 | NTUS-US | Natus Medical Incorporated |
28
|
|
1.4826 %
| NASDAQ | JE00BYSS4X48 | NVCR-US | Novocure Ltd. |
29
|
|
1.4806 %
| NYSE | US4448591028 | HUM-US | Humana Inc. |
30
|
|
1.4797 %
| NYSE | US8636671013 | SYK-US | Stryker Corporation |
31
|
|
1.4775 %
| NASDAQ | US6707041058 | NUVA-US | NuVasive, Inc. |
32
|
|
1.4706 %
| NASDAQ | US5391831030 | LVGO-US | Livongo Health, Inc. |
33
|
|
1.4599 %
| NASDAQ | US46120E6023 | ISRG-US | Intuitive Surgical, Inc. |
34
|
|
1.4597 %
| NASDAQ | US92532F1003 | VRTX-US | Vertex Pharmaceuticals Incorporated |
35
|
|
1.4565 %
| NASDAQ | US45784P1012 | PODD-US | Insulet Corporation |
36
|
|
1.4482 %
| NASDAQ | US2697961082 | EGRX-US | Eagle Pharmaceuticals, Inc. |
37
|
|
1.4454 %
| NASDAQ | US0067391062 | ADUS-US | Addus HomeCare Corporation |
38
|
|
1.4318 %
| NASDAQ | US2521311074 | DXCM-US | DexCom, Inc. |
39
|
|
1.4268 %
| NYSE | US1011371077 | BSX-US | Boston Scientific Corporation |
40
|
|
1.4262 %
| NASDAQ | US53222K2050 | LFVN-US | LifeVantage Corporation |
41
|
|
1.4252 %
| NASDAQ | US8064071025 | HSIC-US | Henry Schein, Inc. |
42
|
|
1.4249 %
| NASDAQ | US5255582018 | LMAT-US | LeMaitre Vascular, Inc. |
43
|
|
1.4225 %
| NYSE | US74834L1008 | DGX-US | Quest Diagnostics Incorporated |
44
|
|
1.4177 %
| NYSE | US98956P1021 | ZBH-US | Zimmer Biomet Holdings, Inc. |
45
|
|
1.4102 %
| NASDAQ | US0311621009 | AMGN-US | Amgen Inc. |
46
|
|
1.4085 %
| NYSE | US58933Y1055 | MRK-US | Merck & Co., Inc. |
47
|
|
1.3961 %
| NYSE | US71944F1066 | PHR-US | Phreesia, Inc. |
48
|
|
1.3942 %
| NASDAQ | US00650F1093 | ADPT-US | Adaptive Biotechnologies Corp. |
49
|
|
1.3933 %
| NYSE | US00287Y1091 | ABBV-US | AbbVie, Inc. |
50
|
|
1.3816 %
| NYSE | IE00BFY8C754 | STE-US | STERIS Plc |
51
|
|
1.3750 %
| NYSE | US28176E1082 | EW-US | Edwards Lifesciences Corporation |
52
|
|
1.3748 %
| NYSE | US1266501006 | CVS-US | CVS Health Corporation |
53
|
|
1.3741 %
| NYSE | US70975L1070 | PEN-US | Penumbra, Inc. |
54
|
|
1.3707 %
| NASDAQ | US4474621020 | HURN-US | Huron Consulting Group Inc. |
55
|
|
1.3628 %
| NASDAQ | US02081G2012 | ATEC-US | Alphatec Holdings, Inc. |
56
|
|
1.3512 %
| NYSE | US4050241003 | HAE-US | Haemonetics Corporation |
57
|
|
1.3276 %
| NASDAQ | US2074101013 | CNMD-US | CONMED Corporation |
58
|
|
1.3202 %
| NASDAQ | US86150R1077 | STOK-US | Stoke Therapeutics, Inc. |
59
|
|
1.3154 %
| NYSE | US3795772082 | GMED-US | Globus Medical, Inc. Class A |
60
|
|
1.3149 %
| NASDAQ | US8125781026 | SGEN-US | Seattle Genetics, Inc. |
61
|
|
1.2788 %
| NASDAQ | US42225T1079 | HCAT-US | Health Catalyst, Inc. |
62
|
|
1.2702 %
| NASDAQ | US2274831047 | CCRN-US | Cross Country Healthcare, Inc. |
63
|
|
1.2153 %
| NASDAQ | US64125C1099 | NBIX-US | Neurocrine Biosciences, Inc. |
64
|
|
1.2080 %
| NASDAQ | US0366421065 | ATRS-US | Antares Pharma, Inc. |
65
|
|
1.1915 %
| NASDAQ | US09060J1060 | BDSI-US | BioDelivery Sciences International, Inc. |
66
|
|
1.1509 %
| NASDAQ | US45337C1027 | INCY-US | Incyte Corporation |
67
|
|
1.1165 %
| NASDAQ | US2321091082 | CUTR-US | Cutera, Inc. |
68
|
|
1.0302 %
| NASDAQ | US2530311081 | DRNA-US | Dicerna Pharmaceuticals, Inc. |
69
|
|
0.9974 %
| NASDAQ | US04280A1007 | ARWR-US | Arrowhead Pharmaceuticals, Inc. |
70
|
